ClinVar Miner

Submissions for variant NM_001127255.1(NLRP7):c.2248C>G (p.Leu750Val) (rs104895512)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000084003 SCV000914854 pathogenic Hydatidiform mole 2018-08-29 criteria provided, single submitter clinical testing The NLRP7 c.2248C>G (p.Leu750Val) variant has been reported three studies and is found in a total of 21 probands with recurrent hydatidiform mole including 15 in a homozygous state, six in a compound heterozygous state, and at least five in a heterozygous state (Kou et al. 2008; Deveault et al. 2009; Estrada et al. 2013). One of the homozygous probands had unaffected parents and sister that were heterozygous for the p.Leu750Val variant (Deveault et al. 2009). The p.Leu750Val variant was reported in five of 460 control chromosomes and is reported at a frequency of 0.005023 in the Latino population of the Exome Aggregation Consortium. Based on the collective evidence, the p.Leu750Val is classified as pathogenic for hydatidiform mole. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Unité médicale des maladies autoinflammatoires, CHRU Montpellier RCV000084003 SCV000116125 not provided Hydatidiform mole no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.